Page last updated: 2024-08-25

sofosbuvir and Iron Overload

sofosbuvir has been researched along with Iron Overload in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Ajdarkosh, H; Amirkalali, B; Faraji, AH; Karbalaie Niya, MH; Khoonsari, M; Maadi, M; Motamed, N; Nikkhah, M; Safarnezhad Tameshkel, F; Sobrakhshankhah, E; Sohrabi, M; Vafaeimanesh, J; Zamani, F	1
Biliotti, E; Esvan, R; Franchi, C; Palazzo, D; Serani, M; Silvestri, AM; Sorrentino, F; Spaziante, M; Taliani, G; Volpicelli, L	1
Anan, A; Inomata, S; Irie, M; Kunimoto, H; Morihara, D; Sakisaka, S; Shakado, S; Sohda, T; Takata, K; Takeyama, Y; Tanaka, T; Yamauchi, E; Yamauchi, R; Yokoyama, K	1

Trials

1 trial(s) available for sofosbuvir and Iron Overload

Article	Year
Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents. Internal medicine (Tokyo, Japan), 2019, Oct-15, Volume: 58, Issue:20 Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Female; Ferritins; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Hepcidins; Humans; Iron; Iron Overload; Male; Middle Aged; Peptide Hormones; Prospective Studies; Sofosbuvir; Uridine Monophosphate	2019

Article

Year

Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.

Internal medicine (Tokyo, Japan), 2019, Oct-15, Volume: 58, Issue:20

Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Female; Ferritins; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Hepcidins; Humans; Iron; Iron Overload; Male; Middle Aged; Peptide Hormones; Prospective Studies; Sofosbuvir; Uridine Monophosphate

2019

Other Studies

2 other study(ies) available for sofosbuvir and Iron Overload

Article	Year
Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study. Archives of medical research, 2022, Volume: 53, Issue:7 Topics: Antiviral Agents; beta-Thalassemia; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Iron Overload; Male; Pyrrolidines; Sofosbuvir; Treatment Outcome	2022
Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major. Annals of hematology, 2017, Volume: 96, Issue:6 Topics: Adult; Antiviral Agents; Benzimidazoles; Benzoates; beta-Thalassemia; Cryoglobulinemia; Deferasirox; Deferoxamine; Elasticity Imaging Techniques; Female; Ferritins; Fluorenes; Hepatitis C, Chronic; Humans; Iron Chelating Agents; Iron Overload; Liver Cirrhosis; Male; Quality of Life; Sofosbuvir; Triazoles; Viral Load	2017

Article

Year

Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study.

Archives of medical research, 2022, Volume: 53, Issue:7

Topics: Antiviral Agents; beta-Thalassemia; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Iron Overload; Male; Pyrrolidines; Sofosbuvir; Treatment Outcome

2022

Interferon free antiviral treatment of chronic hepatitis C in patients affected by β-thalassemia major.

Annals of hematology, 2017, Volume: 96, Issue:6

Topics: Adult; Antiviral Agents; Benzimidazoles; Benzoates; beta-Thalassemia; Cryoglobulinemia; Deferasirox; Deferoxamine; Elasticity Imaging Techniques; Female; Ferritins; Fluorenes; Hepatitis C, Chronic; Humans; Iron Chelating Agents; Iron Overload; Liver Cirrhosis; Male; Quality of Life; Sofosbuvir; Triazoles; Viral Load

2017